Shares of Design Therapeutics experienced a significant surge on Monday following positive results in the treatment of Friedreich's ataxia, reaching an increase of up to 18%. However, the biotech company quickly saw these gains disappear. This fluctuation underscores the volatile nature of the market, illustrating the rapid shifts that can occur in stock value. Investors Business Daily covered this story, highlighting the rollercoaster ride that Design Therapeutics' shares took on this particular day.